EIX-IP Detection

EIX-IP Detection is a pharma-focused intellectual property detection solution developed by expert.ai, purpose-built for pharmaceutical R&D, IP, and legal teams. Unlike general-purpose IP platforms, it integrates patents, scientific literature, and clinical trial data into a single, unified view, enabling organizations to uncover hidden risks and opportunities early — before costly investments or regulatory filings are made.

Built on expert.ai's Hybrid AI framework — combining symbolic AI, machine learning, and large language models — EIX-IP Detection is enriched with curated life sciences data and deep pharmaceutical domain expertise. It is designed to deliver comprehensive, explainable insights that support defensible litigation, regulatory compliance, and strategic competitive intelligence across key therapeutic areas.

What EIX-IP Detection Is For

• Helping legal teams produce explainable, evidence-backed outputs for defensible litigation and compliance processes
• Providing R&D teams with early visibility into IP overlaps to protect costly development programs
• Delivering actionable competitive intelligence mapped to specific therapeutic areas for business and R&D leaders
• Addressing the challenge of sparse, inconsistent information from multiple sources that makes it difficult to build a clear picture of IP activity
• Detecting weak signals — such as early-stage publications or niche patent filings — that traditional IP tools often overlook

Key Capabilities

• Integrated Data Coverage: Monitors patents, scientific publications, and clinical trial registries in a unified environment
• AI Signal Detection: Identifies weak and early-stage signals using similarity and context-based algorithms
• Explainable Insights: Delivers evidence-backed outputs specifically designed for legal and compliance defensibility
• Configurable Taxonomies: Taxonomies can be aligned with specific therapeutic areas and corporate IP strategy
• Secure Access: Role-based, compliant deployment to protect sensitive pharmaceutical data

What You Can Do With EIX-IP Detection

• Strengthen legal and IP teams with intelligent monitoring tools that reduce manual effort and improve accuracy
• Extend surveillance across patents, science, and business domains for comprehensive coverage
• Automate similarity detection and information extraction to reduce errors and omissions
• Accelerate decision making with timely, actionable insights drawn from both structured and unstructured data

Key Benefits

• Proactive IP risk detection across the full pharmaceutical innovation lifecycle
• Comprehensive IP coverage that goes beyond patents to include scientific literature, clinical data, and niche signals
• Improved accuracy, efficiency, and defensibility for IP and legal teams
• Faster, more informed decision making to protect investments and accelerate innovation
• Strategic enablement for pharma legal and R&D leaders

EIX-IP Detection integrates seamlessly with research and regulatory workflows and is deployed in a secure, role-based environment to safeguard sensitive data. Its customizable analytics and explainable AI outputs make it a valuable asset for both strategic planning and legal defense within pharmaceutical organizations.